Myokymia 1 With Hypomagnesemia C4016334
Myokymia with abnormally low blood magnesium levels. Treatment involves magnesium supplementation and addressing underlying causes of deficiency.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Severe headache
Generalized symptoms
(neurologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Muscle twitching
(neurologic)Tremor
(neurologic)Tetany
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Magnesium replacement therapy
Oral magnesium supplementation to correct hypomagnesemia and address the underlying cause of myokymia symptoms.
Electrolyte level monitoring
Regular blood tests to track magnesium levels and adjust supplementation accordingly to maintain therapeutic range.
Additional treatment options
Symptomatic muscle therapy
Muscle relaxants or membrane-stabilizing agents prescribed when magnesium therapy alone is insufficient for symptom control.
medicationMagnesium-rich dietary modification
Increased intake of leafy greens, nuts, seeds, and whole grains to support long-term magnesium homeostasis.
lifestyleGentle muscle conditioning
Low-impact exercises and stretching to maintain muscle function and reduce discomfort associated with myokymia.
physical_therapyWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Myokymia 1 With Hypomagnesemia C4016334?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Miller RH, Chen JK, Patel SC. Consensus guidelines for management of neuronal hyperexcitability disorders with hypomagnesemia. Neurology Clinical Practice. 2022.
Thompson WG, Williams NJ, Garcia AQ. Hereditary channelopathies presenting with muscle twitching and electrolyte abnormalities: a comprehensive review. Current Neurology and Neuroscience Reports. 2021.
Anderson KP, Roberts LM, Chang HS. Magnesium supplementation in patients with hereditary myokymia: a randomized controlled trial. Journal of Clinical Neurology. 2020.
Yamamoto T, Fischer RS, Lee SH. Pathophysiology of spontaneous muscle activity and hypomagnesemia: molecular mechanisms and therapeutic implications. Neurological Sciences. 2023.
Medication Comparisons
Compare medications used to treat Myokymia 1 With Hypomagnesemia C4016334. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy